Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 15;36(4):561-566.
doi: 10.1097/QAD.0000000000003143.

Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes

Affiliations

Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes

Nicolò Girometti et al. AIDS. .

Abstract

Introduction: Preexposure prophylaxis (PrEP) is contributing to achieve a reduction in HIV diagnoses in men having sex with men (MSM). Albeit infrequent, HIV infections in the context of recent PrEP exposure represent a clinical challenge.

Methods: Data on recent PrEP use and possible reasons leading to HIV infection were analysed in individuals newly diagnosed with HIV at 56 Dean Street clinic in 2016-2020. Demographics, immune-virological parameters, genotypic resistance test results and treatment management in this group were compared with those not reporting recent PrEP exposure using Mann-Whitney U test and Fisher's exact test.

Results: Fifty-two of 1030 (5%) individuals reported recent PrEP exposure at HIV diagnosis; 98% were MSM, median age 34 years (interquartile range [IQR] 28-42), 65% of white ethnicity, 65% non-UK-born. 35% reported PrEP intake the day before testing HIV positive, 46% reported sub-optimal PrEP adherence since their last negative HIV test result. Thirty-three of 52 (63%) were self-sourcing PrEP and 9/52 (17%) reported issues with its supply. Recent PrEP use was associated to lower HIV viral load and higher CD4+ cell count at baseline than in counterparts non-recently exposed to PrEP (P < 0.01). M184V mutation was harboured more commonly in the recent PrEP use group (30% vs. 1%, P < 0.01). The proportion of individuals recently exposed to PrEP among those diagnosed with HIV rose sharply, reaching 21% in the first semester of 2020. Viral suppression was achieved by all patients intensified from PrEP to antiretroviral treatment (ART) who remained in care at week 24.

Discussion: Rapid PrEP intensification to ART allowed to achieve high rates of HIV viral suppression despite significant rates of M184V mutation harboured in those newly diagnosed with HIV and reporting recent PrEP exposure.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Funding: SMcC was supported by the Medical Research Council (MC_UU_00004/03).

56 Dean Street Collaborative Group is comprehensive of: Keerti Gedela, Diarmuid Nugent, Sheel Patel and Tara Suchak.

Figures

Fig. 1
Fig. 1
Trends of HIV diagnoses in MSM at 56 Dean Street (grey bars, n), each semester from 2016 to 2020 and rates of MSM newly diagnosed with HIV reporting recent PrEP exposure (black line, values expressed as a %).

References

    1. European Centre for Disease Prevention and Control. HIV infection and AIDS. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC; 2019. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/hiv-infection-a... [Accessed 9 May 2021].
    1. Brown A, Mohammed H, Ogaz D, Kirwan P, Yung M, Nash S, et al. . Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or preexposure prophylaxis (PrEP)?. Eurosurveillance 2017; 22:30553. - PMC - PubMed
    1. UNAIDS, Fast-Tracking Combination Prevention. Reference towards reducing new HIV infections to fewer than 500 000 by 2020. 2015. Available at: https://www.unaids.org/sites/default/files/media_asset/20151019_JC2766_F... [Accessed 10 May 2021].
    1. McCormack S, Dunn DT, Desai M, Dolling D, Gafos M, Gilson R, et al. . Preexposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2016; 387:53–60. - PMC - PubMed
    1. Molina JM, Capitant C, Spire B, Pialux G, Cotte L, Charreau I, et al. . On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med 2015; 373:2237–2246. - PubMed

Publication types